4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-000164
Chairman and CEO bought 17,500 shares at an average $1.57 ($27,507)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-12-28 | Purchase | +1,000 | $1.60 | $1,600 | 11,125,656 | D |
| Niihara Yutaka Chairman and CEO | 2021-12-29 | Purchase | +2,700 | $1.57 | $4,239 | 11,128,356 | D |
| Niihara Yutaka Chairman and CEO | 2021-12-30 | Purchase | +6,800 | $1.56 | $10,608 | 11,135,156 | D |
| Niihara Yutaka Chairman and CEO | 2021-12-31 | Purchase | +7,000 | $1.58 | $11,060 | 11,142,156 | D |
| Open-market purchases · 17,500 sh · avg $1.57 · $27,507 | |||||||
Loading xslF345X03/doc4.xml…